Nafamostat Mesylate Market to Reach USD 112.9 Million by 2032, Growing at 7.8% CAGR
global Nafamostat Mesylate Market is experiencing significant growth due to its critical applications in medical treatments. Nafamostat Mesylate, a synthetic serine proteolytic enzyme inhibitor, is widely used for acute pancreatitis, hemodialysis, and anticoagulation during liver resection.